March 10, 2020
1h ago
Cannabinoids are stepping into the ring to help fight cancer. SōRSE Technology Technology has acquired cancer drug development company Pascal Biosciences and its cannabinoid programs in a deal that values the joint companies at $60 million. SōRSE Technology CEO Howard Lee joined Cheddar to discuss.